AliveCor secures CE Mark on atrial fibrillation algorithm for UK and Ireland

25 January 2015 (Last Updated January 25th, 2015 18:30)

US-based innovator in mobile technology for heart health AliveCor has secured CE Mark clearance for its automated analysis process (algorithm) to detect atrial fibrillation (AF), the most common cause of a stroke.

Alivcor

US-based innovator in mobile technology for heart health AliveCor has secured CE Mark clearance for its automated analysis process (algorithm) to detect atrial fibrillation (AF), the most common cause of a stroke.

The latest version of the AliveECG app provides patients in the UK and Ireland with real-time AF detection in electrocardiogram (ECG) recordings using the AliveCor Heart Monitor.

The Heart Monitor has been developed to record, store and transfer single-channel ECG rhythms, while it will also display ECG rhythms and detects the presence of atrial fibrillation.

Each recorded ECG will be analysed by the new AF Detector, which will automatically notify the user if AF is detected in that ECG.

St Helier Hospital consultant cardiologist Richard Bogle said: "The new AF Detector, along with the tracking of medications and lifestyle factors, will make it easier for me to identify and manage serious heart arrhythmias in my patients.

"My patients will significantly benefit from being able to find out if they are having an AF episode and together it will allow us to determine which medications, habits and activities may be impacting their heart.

"The new AF Detector will make it easier for me to identify and manage serious heart arrhythmias in my patients."

"With a more complete view of what is happening with my patients, even between appointments, we can make better decisions."

The new detector marks a major step in the advancement of mobile health, enabling patients to instantly know if AF is present in their ECG, and immediately take action as recommended by their physician.

AliveCor president and CEO Euan Thomson said: "The UK and Ireland make up more than 20% of our customers and we are excited to now be able to share the AF Detector with them as a powerful tool to help manage their heart conditions.

"The AF Detector, and our continued efforts to support the local community with screening for AF, reconfirm our goal of providing patients and caregivers with clinical-quality, mobile health technology and analysis that can improve heart health."

The new AliveECG app also includes features that help patients and physicians manage existing conditions with intelligent, personalized and new features.


Image: The latest version of the AliveECG app will help patients to detect AF in ECG recordings using the AliveCor Heart Monitor. Photo: courtesy of PRNewswire/ AliveCor, Inc.